Back to explore
Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study
1 Assessments
0 Serious · 0 Some · 1 No · 0 N/A
| Reviewer | Date | Q1.1Does the study have an associated retraction? | Q1.2Does the study have an associated expression of concern or other relevant post-publication notice? | Q1.3Do other studies by the research team highlight causes for concern? | Q2.2Are there concerns relating to the timing or absence of study registration? | Overall | Actions |
|---|---|---|---|---|---|---|---|
| RV012 Lecturer (Teaching & Research) | 30 Oct 2025 | No | No | No | No | No concerns | View |
Publication Details
Journal
Journal of Sleep Research
Publisher
Wiley
Published
8 Oct 2024
ISSN / eISSN
0962-1105 / 1365-2869